Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.

Li X, Moon G, Shin S, Zhang B, Janknecht R.

Mol Med Rep. 2018 Jan 26. doi: 10.3892/mmr.2018.8507. [Epub ahead of print]

PMID:
29393482
2.

YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.

Andrade D, Mehta M, Griffith J, Panneerselvam J, Srivastava A, Kim TD, Janknecht R, Herman T, Ramesh R, Munshi A.

Oncotarget. 2017 Oct 20;8(58):98495-98508. doi: 10.18632/oncotarget.21913. eCollection 2017 Nov 17.

3.

Clipping of arginine-methylated histone tails by JMJD5 and JMJD7.

Liu H, Wang C, Lee S, Deng Y, Wither M, Oh S, Ning F, Dege C, Zhang Q, Liu X, Johnson AM, Zang J, Chen Z, Janknecht R, Hansen K, Marrack P, Li CY, Kappler JW, Hagman J, Zhang G.

Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7717-E7726. doi: 10.1073/pnas.1706831114. Epub 2017 Aug 28.

PMID:
28847961
4.

A PGAM5-KEAP1-Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking.

O'Mealey GB, Plafker KS, Berry WL, Janknecht R, Chan JY, Plafker SM.

J Cell Sci. 2017 Oct 15;130(20):3467-3480. doi: 10.1242/jcs.203216. Epub 2017 Aug 24.

PMID:
28839075
5.

Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood.

McBride JD, Liu X, Berry WL, Janknecht R, Cheng R, Zhou K, Badiavas EV, Ma JX.

Int J Hematol. 2017 Jun;105(6):748-757. doi: 10.1007/s12185-017-2205-5. Epub 2017 Mar 15.

PMID:
28299632
6.

Regulation of the DNA Methylation Landscape in Human Somatic Cell Reprogramming by the miR-29 Family.

Hysolli E, Tanaka Y, Su J, Kim KY, Zhong T, Janknecht R, Zhou XL, Geng L, Qiu C, Pan X, Jung YW, Cheng J, Lu J, Zhong M, Weissman SM, Park IH.

Stem Cell Reports. 2016 Jul 12;7(1):43-54. doi: 10.1016/j.stemcr.2016.05.014. Epub 2016 Jun 30.

7.

ETS transcription factor ERG cooperates with histone demethylase KDM4A.

Kim TD, Shin S, Janknecht R.

Oncol Rep. 2016 Jun;35(6):3679-88. doi: 10.3892/or.2016.4747. Epub 2016 Apr 15.

8.

Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.

Kim TD, Jin F, Shin S, Oh S, Lightfoot SA, Grande JP, Johnson AJ, van Deursen JM, Wren JD, Janknecht R.

J Clin Invest. 2016 Feb;126(2):706-20. doi: 10.1172/JCI78132. Epub 2016 Jan 5.

9.

Upregulation of PSMD10 caused by the JMJD2A histone demethylase.

Kim TD, Oh S, Lightfoot SA, Shin S, Wren JD, Janknecht R.

Int J Clin Exp Med. 2016;9(6):10123-10134. Epub 2016 Jun 30.

10.

Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).

Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ.

Mol Cancer. 2015 Jul 16;14:133. doi: 10.1186/s12943-015-0400-7.

11.

Distinct biochemical and functional properties of two Rab5 homologs from the rice blast fungus Magnaporthe oryzae.

Qi Y, Marlin MC, Liang Z, Berry WL, Janknecht R, Zhou J, Wang Z, Lu G, Li G.

J Biol Chem. 2014 Oct 10;289(41):28299-309. doi: 10.1074/jbc.M114.591503. Epub 2014 Aug 27.

12.

Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.

Kim TD, Fuchs JR, Schwartz E, Abdelhamid D, Etter J, Berry WL, Li C, Ihnat MA, Li PK, Janknecht R.

Am J Transl Res. 2014 May 15;6(3):236-47. eCollection 2014.

13.

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.

Weygant N, Qu D, Berry WL, May R, Chandrakesan P, Owen DB, Sureban SM, Ali N, Janknecht R, Houchen CW.

Mol Cancer. 2014 May 6;13:103. doi: 10.1186/1476-4598-13-103.

14.

Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase.

Berry WL, Kim TD, Janknecht R.

Int J Oncol. 2014 Apr;44(4):1341-8. doi: 10.3892/ijo.2014.2279. Epub 2014 Jan 27.

PMID:
24481461
15.

Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling.

McBride JD, Jenkins AJ, Liu X, Zhang B, Lee K, Berry WL, Janknecht R, Griffin CT, Aston CE, Lyons TJ, Tomasek JJ, Ma JX.

J Invest Dermatol. 2014 Jun;134(6):1725-1734. doi: 10.1038/jid.2014.40. Epub 2014 Jan 24.

16.

Nephrin and Podocin functions are highly conserved between the zebrafish pronephros and mammalian metanephros.

Fukuyo Y, Nakamura T, Bubenshchikova E, Powell R, Tsuji T, Janknecht R, Obara T.

Mol Med Rep. 2014 Feb;9(2):457-65. doi: 10.3892/mmr.2013.1844. Epub 2013 Dec 6.

17.

Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.

Ali N, Allam H, Bader T, May R, Basalingappa KM, Berry WL, Chandrakesan P, Qu D, Weygant N, Bronze MS, Umar S, Janknecht R, Sureban SM, Huycke M, Houchen CW.

PLoS One. 2013 Nov 19;8(11):e80304. doi: 10.1371/journal.pone.0080304. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/fcc840e2-225c-4d71-920d-a1eab7747e19.

18.

14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.

Oh S, Shin S, Lightfoot SA, Janknecht R.

Cancer Res. 2013 Aug 15;73(16):5110-9. doi: 10.1158/0008-5472.CAN-13-0578. Epub 2013 Jun 17.

19.

KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.

Berry WL, Janknecht R.

Cancer Res. 2013 May 15;73(10):2936-42. doi: 10.1158/0008-5472.CAN-12-4300. Epub 2013 May 3. Review.

20.

Developmental localization of nephrin in zebrafish and medaka pronephric glomerulus.

Ichimura K, Fukuyo Y, Nakamura T, Powell R, Sakai T, Janknecht R, Obara T.

J Histochem Cytochem. 2013 Apr;61(4):313-24. doi: 10.1369/0022155413477115. Epub 2013 Jan 15.

21.

ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Shin S, Oh S, An S, Janknecht R.

Oncol Rep. 2013 Jan;29(1):306-14. doi: 10.3892/or.2012.2079. Epub 2012 Oct 16.

22.

Oncogenic features of the JMJD2A histone demethylase in breast cancer.

Berry WL, Shin S, Lightfoot SA, Janknecht R.

Int J Oncol. 2012 Nov;41(5):1701-6. doi: 10.3892/ijo.2012.1618. Epub 2012 Sep 4.

PMID:
22948256
23.

Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation.

Chandra T, Kirschner K, Thuret JY, Pope BD, Ryba T, Newman S, Ahmed K, Samarajiwa SA, Salama R, Carroll T, Stark R, Janky R, Narita M, Xue L, Chicas A, Nũnez S, Janknecht R, Hayashi-Takanaka Y, Wilson MD, Marshall A, Odom DT, Babu MM, Bazett-Jones DP, Tavaré S, Edwards PA, Lowe SW, Kimura H, Gilbert DM, Narita M.

Mol Cell. 2012 Jul 27;47(2):203-14. doi: 10.1016/j.molcel.2012.06.010. Epub 2012 Jul 12.

24.

Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis.

DiTacchio L, Bowles J, Shin S, Lim DS, Koopman P, Janknecht R.

J Biol Chem. 2012 Jul 6;287(28):23657-66. doi: 10.1074/jbc.M111.320101. Epub 2012 May 21.

25.

Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.

Kim TD, Oh S, Shin S, Janknecht R.

PLoS One. 2012;7(4):e34618. doi: 10.1371/journal.pone.0034618. Epub 2012 Apr 13.

26.

ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Oh S, Shin S, Janknecht R.

Biochim Biophys Acta. 2012 Aug;1826(1):1-12. doi: 10.1016/j.bbcan.2012.02.002. Epub 2012 Mar 8. Review.

27.

Histone demethylase JMJD5 is essential for embryonic development.

Oh S, Janknecht R.

Biochem Biophys Res Commun. 2012 Mar 30;420(1):61-5. doi: 10.1016/j.bbrc.2012.02.115. Epub 2012 Feb 28. Erratum in: Biochem Biophys Res Commun. 2015 Sep 11;465(1):166.

PMID:
22402282
28.

The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.

Kim TD, Shin S, Berry WL, Oh S, Janknecht R.

J Cell Biochem. 2012 Apr;113(4):1368-76. doi: 10.1002/jcb.24009.

PMID:
22134899
29.

Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells.

Kimura R, Ishikawa C, Rokkaku T, Janknecht R, Mori N.

Biochim Biophys Acta. 2011 Aug;1813(8):1543-53. doi: 10.1016/j.bbamcr.2011.04.008. Epub 2011 May 27.

30.

Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.

Kim J, Shin S, Subramaniam M, Bruinsma E, Kim TD, Hawse JR, Spelsberg TC, Janknecht R.

Biochem Biophys Res Commun. 2010 Oct 22;401(3):412-6. doi: 10.1016/j.bbrc.2010.09.068. Epub 2010 Sep 20.

31.

Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.

Mooney SM, Goel A, D'Assoro AB, Salisbury JL, Janknecht R.

J Biol Chem. 2010 Oct 1;285(40):30443-52. doi: 10.1074/jbc.M110.143792. Epub 2010 Jul 27.

33.

Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential.

Mooney SM, Grande JP, Salisbury JL, Janknecht R.

Biochemistry. 2010 Jan 12;49(1):1-10. doi: 10.1021/bi901263m.

PMID:
19995069
34.

Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.

Shin S, Kim TD, Jin F, van Deursen JM, Dehm SM, Tindall DJ, Grande JP, Munz JM, Vasmatzis G, Janknecht R.

Cancer Res. 2009 Oct 15;69(20):8102-10. doi: 10.1158/0008-5472.CAN-09-0941. Epub 2009 Sep 29.

35.

Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors.

Hamada S, Kim TD, Suzuki T, Itoh Y, Tsumoto H, Nakagawa H, Janknecht R, Miyata N.

Bioorg Med Chem Lett. 2009 May 15;19(10):2852-5. doi: 10.1016/j.bmcl.2009.03.098. Epub 2009 Mar 26.

PMID:
19359167
36.

Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors.

Shin S, Bosc DG, Ingle JN, Spelsberg TC, Janknecht R.

J Cell Biochem. 2008 Oct 15;105(3):866-74. doi: 10.1002/jcb.21884.

PMID:
18726892
37.

ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification.

Lee D, Park C, Lee H, Lugus JJ, Kim SH, Arentson E, Chung YS, Gomez G, Kyba M, Lin S, Janknecht R, Lim DS, Choi K.

Cell Stem Cell. 2008 May 8;2(5):497-507. doi: 10.1016/j.stem.2008.03.008.

38.

Repression of Smad3 activity by histone demethylase SMCX/JARID1C.

Kim TD, Shin S, Janknecht R.

Biochem Biophys Res Commun. 2008 Feb 8;366(2):563-7. Epub 2007 Dec 17.

PMID:
18078810
39.

Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma.

Smith EH, Janknecht R, Maher LJ 3rd.

Hum Mol Genet. 2007 Dec 15;16(24):3136-48. Epub 2007 Sep 19.

PMID:
17884808
40.

Involvement of RNA helicases p68 and p72 in colon cancer.

Shin S, Rossow KL, Grande JP, Janknecht R.

Cancer Res. 2007 Aug 15;67(16):7572-8.

41.

Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.

Shin S, Janknecht R.

Biochem Biophys Res Commun. 2007 Aug 3;359(3):742-6. Epub 2007 Jun 4.

PMID:
17555712
42.

Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF.

Shin S, Janknecht R.

J Cell Biochem. 2007 Aug 1;101(5):1252-65.

PMID:
17226766
43.

Diversity within the JMJD2 histone demethylase family.

Shin S, Janknecht R.

Biochem Biophys Res Commun. 2007 Feb 23;353(4):973-7. Epub 2006 Dec 27.

PMID:
17207460
44.

Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71.

Knebel J, De Haro L, Janknecht R.

J Cell Biochem. 2006 Sep 1;99(1):319-29.

PMID:
16619273
45.

EWS-ETS oncoproteins: the linchpins of Ewing tumors.

Janknecht R.

Gene. 2005 Dec 19;363:1-14. Epub 2005 Oct 3. Review.

PMID:
16202544
46.

Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter.

De Haro L, Janknecht R.

Genomics. 2005 Apr;85(4):493-502.

PMID:
15780752
47.

Overexpression of the TGF-beta antagonist Smad7 in endometrial cancer.

Dowdy SC, Mariani A, Reinholz MM, Keeney GL, Spelsberg TC, Podratz KC, Janknecht R.

Gynecol Oncol. 2005 Feb;96(2):368-73.

PMID:
15661223
48.

hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.

Fuchs B, Inwards C, Scully SP, Janknecht R.

Clin Orthop Relat Res. 2004 Sep;(426):64-8.

PMID:
15346053
49.

On the road to immortality: hTERT upregulation in cancer cells.

Janknecht R.

FEBS Lett. 2004 Apr 23;564(1-2):9-13. Review.

Supplemental Content

Loading ...
Support Center